Skip to main content
. 2022 Oct 26;11(21):6314. doi: 10.3390/jcm11216314

Figure 1.

Figure 1

Time and dose-dependent effect of abelacimab on bound FXI (left panel) and aPTT (right panel) following monthly s.c. administration. Ratios were calculated by dividing by the subject’s baseline values. Modified from Yi A.B. et al. [22]. F: factor; aPTT: activated partial thromboplastin time.